transCampus Seminar Series on allogeneic hematopoietic cell transplantation
Prof. Francesco Dazzi, King’s, Head of Regenerative Medicine, Dr. Victoria Potter, King’s, Cancer Clinical Academic Group; Prof. Martin Bornhäuser, TUD, Stem Cell Lab I
As the pandemic situation has limited travel and exchange throughout the last twelve months, Francesco Dazzi, Victoria Potter and Martin Bornhäuser, together with colleagues from King’s and TUD have initiated an interactive lecture series on specific aspects of allogeneic hematopoietic cell transplantation. Brief state-of-the art lectures will be followed by case-vignettes on clinical problems with one colleague from King’s and TUD each, discussing local policies and general therapeutic approaches.
The target audience are clinical fellows in hematology/transplantation who are in the first years of their residence. A limited size audience (i.e., 10 fellows from King’s and TUD) allow for personal interaction and problem-based approaches.
The seminar series has started in September on a bi-weekly schedule and lasts for 45-60 min, including QA sessions and feedback. Lectures will be recorded and materials supplied to participants.
The scheduled topics are:
- Indications for allogeneic hematopoietic cell transplantation
- How to select the right donor: Immunogenetic basics and algorithms
- Choice of conditioning therapy: RIC or what it’s all about
- Mobilization of hematopoietic cells for allografting: What’s the target?
- How to collect and process bone marrow (Practical aspects and GMP)
- Clinical scale cell selection
- GvHD prophylaxis: Serotherapy vs. pTCy and other aspects
- Prophylaxis and management of CMV infection
- Prophylaxis and management of fungal infection
- Cellular therapy for viral infections
- Therapy of acute GvHD: When and what?
- Chronic GvHD: Is there really any effective therapy?
- Allogeneic HCT or CAR T cells: What’s the current score?